Oral administered particulate yeast-derived glucan promotes hepatitis B virus clearance in a hydrodynamic injection mouse model

scientific article published on 9 April 2015

Oral administered particulate yeast-derived glucan promotes hepatitis B virus clearance in a hydrodynamic injection mouse model is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2015PLoSO..1023559Y
P356DOI10.1371/JOURNAL.PONE.0123559
P932PMC publication ID4391928
P698PubMed publication ID25856080
P5875ResearchGate publication ID274725181

P50authorXiaonan ZhangQ58209903
Maya KozlowskiQ105418491
P2093author name stringZhenghong Yuan
Min Wu
Xiaohui Zhou
Dandan Zhang
Cong Wang
Zhong Fang
Xiaoyu Yu
Bisheng Shi
Guangxu Ren
Xiuhua Peng
P2860cites workThe beta-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineagesQ28203122
Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor modelsQ28270755
Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discoveryQ31039477
Orally Administered Particulate β-Glucan Modulates Tumor-Capturing Dendritic Cells and Improves Antitumor T-Cell Responses in CancerQ34267746
The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cellsQ34629141
Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucansQ35083249
Viral Clearance Without Destruction of Infected Cells During Acute HBV InfectionQ56951258
Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patientsQ81484423
Hepatitis B virus infectionQ83352950
Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responsesQ84595633
An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infectionQ35128696
Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liverQ36349612
Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2.Q36370968
TLR2 is expressed on activated T cells as a costimulatory receptorQ36853515
beta-Glucans in promoting health: prevention against mutation and cancer.Q36934959
GS-9620, an oral agonist of Toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzeesQ36950984
Managing HBV in patients with impaired immunityQ37762927
Immunity and immunopathology to viruses: what decides the outcome?Q37767587
Molecular genetics of HBV infection.Q37805980
Glucan-immunostimulant, adjuvant, potential drugQ37878306
Immune control of hepatitis B virus.Q37926861
The effects of β-glucans on dendritic cells and implications for cancer therapyQ38054853
Changes of HBsAg and HBV DNA levels in Chinese chronic hepatitis B patients after 5 years of entecavir treatmentQ42249938
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infectionQ42797242
Characterization of the liver tissue interstitial fluid (TIF) proteome indicates potential for application in liver disease biomarker discoveryQ44412694
Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.Q44644460
Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infectionQ45351622
Dectin-1 synergizes with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophagesQ46543832
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectHepatitis B virusQ6844
P304page(s)e0123559
P577publication date2015-04-09
P1433published inPLOS OneQ564954
P1476titleOral administered particulate yeast-derived glucan promotes hepatitis B virus clearance in a hydrodynamic injection mouse model
P478volume10